Gallium-68 NOTA AE105 (Curasight)
- Generic Name
- Gallium-68 NOTA AE105 (Curasight)
Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)
Phase 3
Not yet recruiting
- Conditions
- CanitiesGrey Hair
- Interventions
- Drug: Placebo Topical Solution
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT06745336
uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness
- First Posted Date
- 2017-10-11
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 52
- Registration Number
- NCT03307460
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer
- First Posted Date
- 2016-11-16
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 57
- Registration Number
- NCT02965001
- Locations
- 🇩🇰
Departmen of Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath